AD Prevalence Rates in Cohort Subgroups, as Indicated by Clinical and Imaging Diagnostic Markers
| Selected subgroup | AD prevalence rate in subgroup | AD prevalence rate in cohort | |||||
| Identification | Description | 11C-PiB | 18F-FDG | Clinical | 11C-PiB | 18F-FDG | Clinical |
| 1 | 11C-PiB imaging for AD | 1.00 | 0.86 | 0.75 | 0.54 | 0.47 | 0.40 |
| 2 | 18F-FDG imaging for AD | 0.90 | 1.00 | 0.73 | 0.47 | 0.52 | 0.38 |
| 3 | Clinical AD | 0.88 | 0.75 | 1.00 | 0.22 | 0.19 | 0.26 |
| 4 | Clinical PPA-L (AD variant) | 0.89 | 0.95 | 1.00 | 0.18 | 0.19 | 0.20 |
| 5 | Clinical PPA-G | 0.31 | 0.25 | 0.00 | 0.05 | 0.04 | 0.00 |
| 6 | Clinical PPA-S | 0.08 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| 7 | Clinical CBS | 0.36 | 0.50 | 0.00 | 0.05 | 0.07 | 0.00 |
| 8 | Clinical AD and PPA-L | 0.88 | 0.84 | 1.00 | 0.40 | 0.38 | 0.46 |
| 9 | Clinical PPA-G, PPA-S, and CBS | 0.26 | 0.26 | 0.00 | 0.12 | 0.12 | 0.00 |
| 10 | Entire cohort | 0.54 | 0.52 | 0.46 | 0.54 | 0.52 | 0.46 |